Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

257 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.
Gillison ML, Trotti AM, Harris J, Eisbruch A, Harari PM, Adelstein DJ, Jordan RCK, Zhao W, Sturgis EM, Burtness B, Ridge JA, Ringash J, Galvin J, Yao M, Koyfman SA, Blakaj DM, Razaq MA, Colevas AD, Beitler JJ, Jones CU, Dunlap NE, Seaward SA, Spencer S, Galloway TJ, Phan J, Dignam JJ, Le QT. Gillison ML, et al. Among authors: ringash j. Lancet. 2019 Jan 5;393(10166):40-50. doi: 10.1016/S0140-6736(18)32779-X. Epub 2018 Nov 15. Lancet. 2019. PMID: 30449625 Free PMC article. Clinical Trial.
Conformal radiotherapy in the adjuvant treatment of gastric cancer: Review of 82 cases.
Kassam Z, Lockwood G, O'brien C, Brierley J, Swallow C, Oza A, Siu L, Knox JJ, Wong R, Cummings B, Kim J, Moore M, Ringash J. Kassam Z, et al. Among authors: ringash j. Int J Radiat Oncol Biol Phys. 2006 Jul 1;65(3):713-9. doi: 10.1016/j.ijrobp.2006.01.001. Epub 2006 Apr 19. Int J Radiat Oncol Biol Phys. 2006. PMID: 16626887
Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): a phase III trial of the Trans-Tasman Radiation Oncology Group.
Rischin D, Peters LJ, O'Sullivan B, Giralt J, Fisher R, Yuen K, Trotti A, Bernier J, Bourhis J, Ringash J, Henke M, Kenny L. Rischin D, et al. Among authors: ringash j. J Clin Oncol. 2010 Jun 20;28(18):2989-95. doi: 10.1200/JCO.2009.27.4449. Epub 2010 May 17. J Clin Oncol. 2010. PMID: 20479425 Clinical Trial.
Cognitive functioning after radiotherapy or chemoradiotherapy for head-and-neck cancer.
Gan HK, Bernstein LJ, Brown J, Ringash J, Vakilha M, Wang L, Goldstein D, Kim J, Hope A, O'Sullivan B, Waldron J, Abdul Razak AR, Chen EX, Siu LL. Gan HK, et al. Among authors: ringash j. Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):126-34. doi: 10.1016/j.ijrobp.2010.05.004. Epub 2010 Aug 12. Int J Radiat Oncol Biol Phys. 2011. PMID: 20708851
Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy.
Huang SH, Perez-Ordonez B, Liu FF, Waldron J, Ringash J, Irish J, Cummings B, Siu LL, Kim J, Weinreb I, Hope A, Gullane P, Brown D, Shi W, O'Sullivan B. Huang SH, et al. Among authors: ringash j. Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):276-83. doi: 10.1016/j.ijrobp.2010.08.031. Epub 2010 Oct 13. Int J Radiat Oncol Biol Phys. 2012. PMID: 20950953
Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation.
O'Sullivan B, Huang SH, Perez-Ordonez B, Massey C, Siu LL, Weinreb I, Hope A, Kim J, Bayley AJ, Cummings B, Ringash J, Dawson LA, Cho BC, Chen E, Irish J, Gilbert RW, Hui A, Liu FF, Zhao H, Waldron JN, Xu W. O'Sullivan B, et al. Among authors: ringash j. Radiother Oncol. 2012 Apr;103(1):49-56. doi: 10.1016/j.radonc.2012.02.009. Epub 2012 Mar 10. Radiother Oncol. 2012. PMID: 22410204
Patient preferences for oropharyngeal cancer treatment de-escalation.
Brotherston DC, Poon I, Le T, Leung M, Kiss A, Ringash J, Balogh J, Lee J, Wright JR. Brotherston DC, et al. Among authors: ringash j. Head Neck. 2013 Feb;35(2):151-9. doi: 10.1002/hed.22930. Epub 2012 Mar 20. Head Neck. 2013. PMID: 22431201
Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer.
Huang SH, Perez-Ordonez B, Weinreb I, Hope A, Massey C, Waldron JN, Kim J, Bayley AJ, Cummings B, Cho BC, Ringash J, Dawson LA, Siu LL, Chen E, Irish J, Gullane P, Hui A, Liu FF, Shen X, Xu W, O'Sullivan B. Huang SH, et al. Among authors: ringash j. Oral Oncol. 2013 Jan;49(1):79-85. doi: 10.1016/j.oraloncology.2012.07.015. Epub 2012 Aug 20. Oral Oncol. 2013. PMID: 22917550
Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis.
O'Sullivan B, Huang SH, Siu LL, Waldron J, Zhao H, Perez-Ordonez B, Weinreb I, Kim J, Ringash J, Bayley A, Dawson LA, Hope A, Cho J, Irish J, Gilbert R, Gullane P, Hui A, Liu FF, Chen E, Xu W. O'Sullivan B, et al. Among authors: ringash j. J Clin Oncol. 2013 Feb 10;31(5):543-50. doi: 10.1200/JCO.2012.44.0164. Epub 2013 Jan 7. J Clin Oncol. 2013. PMID: 23295795
Phase III randomized, placebo-controlled study of cetuximab plus brivanib alaninate versus cetuximab plus placebo in patients with metastatic, chemotherapy-refractory, wild-type K-RAS colorectal carcinoma: the NCIC Clinical Trials Group and AGITG CO.20 Trial.
Siu LL, Shapiro JD, Jonker DJ, Karapetis CS, Zalcberg JR, Simes J, Couture F, Moore MJ, Price TJ, Siddiqui J, Nott LM, Charpentier D, Liauw W, Sawyer MB, Jefford M, Magoski NM, Haydon A, Walters I, Ringash J, Tu D, O'Callaghan CJ. Siu LL, et al. Among authors: ringash j. J Clin Oncol. 2013 Jul 1;31(19):2477-84. doi: 10.1200/JCO.2012.46.0543. Epub 2013 May 20. J Clin Oncol. 2013. PMID: 23690424 Clinical Trial.
Temporal nodal regression and regional control after primary radiation therapy for N2-N3 head-and-neck cancer stratified by HPV status.
Huang SH, O'Sullivan B, Xu W, Zhao H, Chen DD, Ringash J, Hope A, Razak A, Gilbert R, Irish J, Kim J, Dawson LA, Bayley A, Cho BC, Goldstein D, Gullane P, Yu E, Perez-Ordonez B, Weinreb I, Waldron J. Huang SH, et al. Among authors: ringash j. Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):1078-85. doi: 10.1016/j.ijrobp.2013.08.049. Epub 2013 Oct 24. Int J Radiat Oncol Biol Phys. 2013. PMID: 24210079
Outcomes toolbox for head and neck cancer research.
Ringash J, Bernstein LJ, Cella D, Logemann J, Movsas B, Murphy B, Trotti A, Wells N, Yueh B, Ridge J. Ringash J, et al. Head Neck. 2015 Mar;37(3):425-39. doi: 10.1002/hed.23561. Epub 2015 Jan 22. Head Neck. 2015. PMID: 24318166 Review.
Induction gemcitabine plus concurrent gemcitabine and radiotherapy for locally advanced unresectable or resected pancreatic cancer.
Youl M, Hashem S, Brade A, Cummings B, Dawson LA, Gallinger S, Hedley D, Jiang H, Kim J, Krzyzanowska MK, Ringash J, Wong R, Brierley J. Youl M, et al. Among authors: ringash j. Clin Oncol (R Coll Radiol). 2014 Apr;26(4):203-9. doi: 10.1016/j.clon.2014.01.003. Epub 2014 Jan 23. Clin Oncol (R Coll Radiol). 2014. PMID: 24462333 Clinical Trial.
Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer.
Han K, Cummings BJ, Lindsay P, Skliarenko J, Craig T, Le LW, Brierley J, Wong R, Dinniwell R, Bayley AJ, Dawson LA, Ringash J, Krzyzanowska MK, Moore MJ, Chen EX, Easson AM, Kassam Z, Cho C, Kim J. Han K, et al. Among authors: ringash j. Int J Radiat Oncol Biol Phys. 2014 Nov 1;90(3):587-94. doi: 10.1016/j.ijrobp.2014.06.061. Epub 2014 Sep 3. Int J Radiat Oncol Biol Phys. 2014. PMID: 25194664
Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status.
Huang SH, Waldron JN, Milosevic M, Shen X, Ringash J, Su J, Tong L, Perez-Ordonez B, Weinreb I, Bayley AJ, Kim J, Hope A, Cho BC, Giuliani M, Razak A, Goldstein D, Shi W, Liu FF, Xu W, O'Sullivan B. Huang SH, et al. Among authors: ringash j. Cancer. 2015 Feb 15;121(4):545-55. doi: 10.1002/cncr.29100. Epub 2014 Oct 21. Cancer. 2015. PMID: 25336438 Free article.
Adjuvant sunitinib following chemoradiotherapy and surgery for locally advanced esophageal cancer: a phase II trial.
Horgan AM, Darling G, Wong R, Guindi M, Liu G, Jonker DJ, Lister J, Xu W, MacKay HM, Dinniwell R, Kim J, Pierre A, Shargall Y, Asmis TR, Agboola O, Seely AJ, Ringash J, Wells J, Marginean EC, Haider M, Knox JJ. Horgan AM, et al. Among authors: ringash j. Dis Esophagus. 2016 Nov;29(8):1152-1158. doi: 10.1111/dote.12444. Epub 2015 Dec 10. Dis Esophagus. 2016. PMID: 26663741 Clinical Trial.
Effect of p16 Status on the Quality-of-Life Experience During Chemoradiation for Locally Advanced Oropharyngeal Cancer: A Substudy of Randomized Trial Trans-Tasman Radiation Oncology Group (TROG) 02.02 (HeadSTART).
Ringash J, Fisher R, Peters L, Trotti A, O'Sullivan B, Corry J, Kenny L, Nuyts S, Wratten C, Rischin D. Ringash J, et al. Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):678-686. doi: 10.1016/j.ijrobp.2016.03.017. Epub 2016 Mar 23. Int J Radiat Oncol Biol Phys. 2017. PMID: 27209505 Clinical Trial.
Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.
Spreafico A, Huang SH, Xu W, Granata R, Liu CS, Waldron JN, Chen E, Ringash J, Bayley A, Chan KK, Hope AJ, Cho J, Razak AA, Hansen A, Jang R, Perez-Ordonez B, Weinreb I, Bossi P, Orlandi E, Licitra LF, Song Y, O'Sullivan B, Siu LL, Kim J. Spreafico A, et al. Among authors: ringash j. Eur J Cancer. 2016 Nov;67:174-182. doi: 10.1016/j.ejca.2016.08.013. Epub 2016 Sep 24. Eur J Cancer. 2016. PMID: 27669504
Phase 1/2 Study of the Addition of Cisplatin to Adjuvant Chemotherapy With Image Guided High-Precision Radiation Therapy for Completely Resected Gastric Cancer.
Goody RB, MacKay H, Pitcher B, Oza A, Siu LL, Kim J, Wong RK, Chen E, Swallow C, Knox J, Kassam Z, Cummings B, Feld R, Hedley D, Liu G, Krzyzanowska MK, Dinniwell R, Brade AM, Dawson LA, Pintilie M, Ringash J. Goody RB, et al. Among authors: ringash j. Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):994-1002. doi: 10.1016/j.ijrobp.2016.08.034. Epub 2016 Aug 31. Int J Radiat Oncol Biol Phys. 2016. PMID: 27745984 Clinical Trial.
Distant Metastases Following Postoperative Intensity-Modulated Radiotherapy for Oral Cavity Squamous Cell Carcinoma.
Hosni A, Huang SH, Xu W, Su J, Bayley A, Bratman SV, Cho J, Giuliani M, Kim J, Ringash J, Waldron J, Spreafico A, De Almeidad J, O'Sullivan B, Goldstein D, Hope A. Hosni A, et al. Among authors: ringash j. JAMA Otolaryngol Head Neck Surg. 2017 Apr 1;143(4):368-375. doi: 10.1001/jamaoto.2016.3668. JAMA Otolaryngol Head Neck Surg. 2017. PMID: 28033442
Effect of Intensity Modulated Radiation Therapy With Concurrent Chemotherapy on Survival for Patients With Cervical Esophageal Carcinoma.
McDowell LJ, Huang SH, Xu W, Che J, Wong RKS, Brierley J, Kim J, Cummings B, Waldron J, Bayley A, Hansen A, Witterick I, Ringash J. McDowell LJ, et al. Among authors: ringash j. Int J Radiat Oncol Biol Phys. 2017 May 1;98(1):186-195. doi: 10.1016/j.ijrobp.2017.01.003. Epub 2017 Jan 9. Int J Radiat Oncol Biol Phys. 2017. PMID: 28258892
Exploring the Impact of Human Papillomavirus Status, Comorbidity, Polypharmacy, and Treatment Intensity on Outcome of Elderly Oropharyngeal Cancer Patients Treated With Radiation Therapy With or Without Chemotherapy.
Caparrotti F, O'Sullivan B, Bratman SV, Ringash J, Lu L, Bayley A, Cho J, Giuliani M, Hope A, Kim J, Waldron J, Hansen A, Goldstein D, Perez-Ordonez B, Weinreb I, Tong L, Song Y, Xu W, Huang SH. Caparrotti F, et al. Among authors: ringash j. Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):858-867. doi: 10.1016/j.ijrobp.2016.11.044. Epub 2016 Nov 27. Int J Radiat Oncol Biol Phys. 2017. PMID: 28258893
Re-evaluation of Ipsilateral Radiation for T1-T2N0-N2b Tonsil Carcinoma at the Princess Margaret Hospital in the Human Papillomavirus Era, 25 Years Later.
Huang SH, Waldron J, Bratman SV, Su J, Kim J, Bayley A, Cho J, Giuliani M, Hope A, Ringash J, Hansen A, de Almeida JR, Goldstein D, Perez-Ordonez B, Weinreb I, Tong L, Xu W, O'Sullivan B. Huang SH, et al. Among authors: ringash j. Int J Radiat Oncol Biol Phys. 2017 May 1;98(1):159-169. doi: 10.1016/j.ijrobp.2017.01.018. Epub 2017 Jan 9. Int J Radiat Oncol Biol Phys. 2017. PMID: 28258895
Morphologic and topographic radiologic features of human papillomavirus-related and -unrelated oropharyngeal carcinoma.
Chan MW, Yu E, Bartlett E, O'Sullivan B, Su J, Waldron J, Ringash J, Bratman SV, Chen YA, Irish J, Kim J, Gullane P, Gilbert R, Chepeha D, Perez-Ordonez B, Weinreb I, Hansen A, Tong L, Xu W, Huang SH. Chan MW, et al. Among authors: ringash j. Head Neck. 2017 Aug;39(8):1524-1534. doi: 10.1002/hed.24764. Epub 2017 Jun 5. Head Neck. 2017. PMID: 28580605
Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity-modulated radiotherapy.
Caparrotti F, Huang SH, Lu L, Bratman SV, Ringash J, Bayley A, Cho J, Giuliani M, Kim J, Waldron J, Hansen A, Tong L, Xu W, O'Sullivan B, Wood R, Goldstein D, Hope A. Caparrotti F, et al. Among authors: ringash j. Cancer. 2017 Oct 1;123(19):3691-3700. doi: 10.1002/cncr.30803. Epub 2017 Jun 13. Cancer. 2017. PMID: 28608925 Free article.
Partial Laryngeal IMRT for T2N0 Glottic Cancer: Impact of Image Guidance and Radiation Therapy Intensification.
Rock K, Huang SH, Tiong A, Lu L, Xu W, Ringash J, Bratman SV, Tong L, Chan B, Cho J, Giuliani M, Hope A, Bayley A, Kim J, de Almeida JR, O'Sullivan B, Waldron J. Rock K, et al. Among authors: ringash j. Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):941-949. doi: 10.1016/j.ijrobp.2018.03.034. Epub 2018 Mar 30. Int J Radiat Oncol Biol Phys. 2018. PMID: 29730062
Radiologic Extranodal Extension Portends Worse Outcome in cN+ TNM-8 Stage I Human Papillomavirus-Mediated Oropharyngeal Cancer.
Billfalk-Kelly A, Yu E, Su J, O'Sullivan B, Waldron J, Ringash J, Bartlett E, Perez-Ordonez B, Weinreb I, Bayley A, Bratman SV, Cho J, Giuliani M, Hope A, Hosni A, Kim J, Hansen AR, de Almeida J, Tong L, Xu W, Huang SH. Billfalk-Kelly A, et al. Among authors: ringash j. Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):1017-1027. doi: 10.1016/j.ijrobp.2019.03.047. Epub 2019 Apr 4. Int J Radiat Oncol Biol Phys. 2019. PMID: 30953712
Validation of distant metastases risk-groups in oral cavity squamous cell carcinoma patients treated with postoperative intensity-modulated radiotherapy.
Hosni A, Huang SH, Chiu K, Xu W, Su J, Lu L, Bayley A, Bratman SV, Cho J, Giuliani M, Kim J, O'Sullivan B, Ringash J, Waldron J, Spreafico A, de Almeida JR, Chepeha DB, Irish JC, Goldstein DP, Hope A. Hosni A, et al. Among authors: ringash j. Radiother Oncol. 2019 May;134:10-16. doi: 10.1016/j.radonc.2019.01.014. Epub 2019 Jan 31. Radiother Oncol. 2019. PMID: 31005202
Impact of cisplatin dose and smoking pack-years in human papillomavirus-positive oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.
Oliva M, Huang SH, Xu W, Su J, Hansen AR, Bratman SV, Ringash J, Jang R, Cho J, Bayley A, Hope AJ, Chen E, Giuliani M, Waldron J, Weinreb I, Perez-Ordonez B, Chepeha D, Kim J, O Sullivan B, Siu LL, Spreafico A. Oliva M, et al. Among authors: ringash j. Eur J Cancer. 2019 Sep;118:112-120. doi: 10.1016/j.ejca.2019.06.019. Epub 2019 Jul 19. Eur J Cancer. 2019. PMID: 31330486
Treatment outcomes in oropharynx cancer patients who did not complete planned curative radiotherapy.
Alfaraj F, Craig T, Huang SH, O'Sullivan B, Su J, Bayley A, Bratman S, Cho J, Giuliani M, Kim J, Ringash J, Waldron J, Hansen A, de Almeida J, Perez-Ordonez B, Weinreb I, Tong L, Xu W, Hope A. Alfaraj F, et al. Among authors: ringash j. Oral Oncol. 2019 Oct;97:124-130. doi: 10.1016/j.oraloncology.2019.05.012. Epub 2019 Sep 11. Oral Oncol. 2019. PMID: 31521053
Prognostic importance of radiologic extranodal extension in HPV-positive oropharyngeal carcinoma and its potential role in refining TNM-8 cN-classification.
Huang SH, O'Sullivan B, Su J, Bartlett E, Kim J, Waldron JN, Ringash J, de Almeida JR, Bratman S, Hansen A, Bayley A, Cho J, Giuliani M, Hope A, Hosni A, Spreafico A, Siu L, Chepeha D, Tong L, Xu W, Yu E. Huang SH, et al. Among authors: ringash j. Radiother Oncol. 2020 Mar;144:13-22. doi: 10.1016/j.radonc.2019.10.011. Epub 2019 Nov 8. Radiother Oncol. 2020. PMID: 31710939
Impact of cumulative cisplatin dose and adjuvant chemotherapy in locally-advanced nasopharyngeal carcinoma treated with definitive chemoradiotherapy.
Oliva M, Huang SH, Taylor R, Su J, Xu W, Hansen AR, Jang R, Bayley A, Hosni A, Giuliani M, Ringash J, Bratman SV, Cho J, Irish J, Waldron J, Weinreb I, Kim J, O'Sullivan B, Siu LL, Spreafico A. Oliva M, et al. Among authors: ringash j. Oral Oncol. 2020 Jun;105:104666. doi: 10.1016/j.oraloncology.2020.104666. Epub 2020 Apr 6. Oral Oncol. 2020. PMID: 32272384
Phase I trial of alpelisib in combination with concurrent cisplatin-based chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck.
Day D, Prawira A, Spreafico A, Waldron J, Karithanam R, Giuliani M, Weinreb I, Kim J, Cho J, Hope A, Bayley A, Ringash J, Bratman SV, Jang R, O'Sullivan B, Siu LL, Hansen AR. Day D, et al. Among authors: ringash j. Oral Oncol. 2020 Sep;108:104753. doi: 10.1016/j.oraloncology.2020.104753. Epub 2020 May 25. Oral Oncol. 2020. PMID: 32464516 Clinical Trial.
Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal.
Huang SH, O'Sullivan B, Su J, Ringash J, Bratman SV, Kim J, Hosni A, Bayley A, Cho J, Giuliani M, Hope A, Spreafico A, Hansen AR, Siu LL, Gilbert R, Irish JC, Goldstein D, de Almeida J, Tong L, Xu W, Waldron J. Huang SH, et al. Among authors: ringash j. Cancer. 2020 Aug 1;126(15):3426-3437. doi: 10.1002/cncr.32968. Epub 2020 Jun 1. Cancer. 2020. PMID: 32478895 Free PMC article. Clinical Trial.
Non-operative management for oral cavity carcinoma: Definitive radiation therapy as a potential alternative treatment approach.
Hosni A, Chiu K, Huang SH, Xu W, Huang J, Bayley A, Bratman SV, Cho J, Giuliani M, Kim J, O'Sullivan B, Ringash J, Waldron J, Spreafico A, de Almeida JR, Monteiro E, Witterick I, Chepeha DB, Gilbert RW, Irish JC, Goldstein DP, Hope A. Hosni A, et al. Among authors: ringash j. Radiother Oncol. 2021 Jan;154:70-75. doi: 10.1016/j.radonc.2020.08.013. Epub 2020 Aug 28. Radiother Oncol. 2021. PMID: 32861702 Free PMC article.
Pre- and Post-Radiotherapy Radiologic Nodal Features and Oropharyngeal Cancer Outcomes.
Sananmuang T, Yu E, Su J, O'Sullivan B, Rathod S, Chan B, Bartlett E, Waldron J, Ringash J, Kim J, Bratman SV, Hope A, Spreafico A, Hansen AR, de Almeida J, Goldstein DP, Witterick I, Tong L, Xu W, Huang SH. Sananmuang T, et al. Among authors: ringash j. Laryngoscope. 2021 Apr;131(4):E1162-E1171. doi: 10.1002/lary.29045. Epub 2020 Oct 1. Laryngoscope. 2021. PMID: 33002201
Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer.
Jiang DM, Sim HW, Espin-Garcia O, Chan BA, Natori A, Lim CH, Moignard S, Chen EX, Liu G, Darling G, Swallow CJ, Brar S, Brierley J, Ringash J, Wong R, Kim J, Rogalla P, Hafezi-Bakhtiari S, Knox JJ, Jang RW, Elimova E. Jiang DM, et al. Among authors: ringash j. Oncology. 2021;99(1):49-56. doi: 10.1159/000510446. Epub 2020 Oct 14. Oncology. 2021. PMID: 33053548 Free article.
Short-term and long-term unstimulated saliva flow following unilateral vs bilateral radiotherapy for oropharyngeal carcinoma.
Huang SH, de Almeida JR, Watson E, Glogauer M, Xu W, Keshavarzi S, O'Sullivan B, Ringash J, Hope A, Bayley A, Bratman SV, Cho J, Giuliani M, Kim J, Waldron J, Spreafico A, Goldstein DP, Chepeha DB, Li T, Hosni A. Huang SH, et al. Among authors: ringash j. Head Neck. 2021 Feb;43(2):456-466. doi: 10.1002/hed.26496. Epub 2020 Oct 15. Head Neck. 2021. PMID: 33058305 Review.
Healthcare resource utilization following unilateral versus bilateral radiation therapy for oropharyngeal carcinoma.
Hosni A, Huang SH, Xu W, Su J, Watson E, Glogauer M, Bayley A, Bratman SV, Cho J, Giuliani M, Hope A, Kim J, O'Sullivan B, Ringash J, Spreafico A, Goldstein DP, Waldron J, de Almeida JR. Hosni A, et al. Among authors: ringash j. Radiother Oncol. 2021 Mar;156:95-101. doi: 10.1016/j.radonc.2020.11.028. Epub 2020 Nov 29. Radiother Oncol. 2021. PMID: 33264637
Head and neck imaging surveillance strategy for HPV-positive oropharyngeal carcinoma following definitive (chemo)radiotherapy.
Wong ET, Huang SH, O'Sullivan B, Persaud V, Su J, Waldron J, Goldstein DP, de Almeida J, Ringash J, Kim J, Hope A, Bratman S, Cho J, Giuliani M, Hosni A, Spreafico A, Hansen A, Tong L, Xu W, Yu E. Wong ET, et al. Among authors: ringash j. Radiother Oncol. 2021 Apr;157:255-262. doi: 10.1016/j.radonc.2021.02.005. Epub 2021 Feb 16. Radiother Oncol. 2021. PMID: 33600871
Out-of-pocket costs associated with head and neck cancer treatment.
Khan MN, Hueniken K, Manojlovic-Kolarski M, Eng L, Mirshams M, Khan K, Simpson C, Au M, Liu G, Xu W, Longo CJ, Goldstein DP, Ringash J, Martino R, Hansen AR, de Almeida JR. Khan MN, et al. Among authors: ringash j. Cancer Rep (Hoboken). 2022 Jul;5(7):e1528. doi: 10.1002/cnr2.1528. Epub 2021 Aug 24. Cancer Rep (Hoboken). 2022. PMID: 34428351 Free PMC article.
Treatment outcomes and survival following definitive (chemo)radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohorts.
Lassen P, Huang SH, Su J, Waldron J, Andersen M, Primdahl H, Johansen J, Kristensen CA, Andersen E, Eriksen JG, Hansen CR, Alsner J, Lilja-Fisher J, Bratman SV, Ringash J, Kim J, Hope A, Spreafico A, de Almeida J, Xu W, O'Sullivan B, Overgaard J. Lassen P, et al. Among authors: ringash j. Int J Cancer. 2022 Apr 15;150(8):1329-1340. doi: 10.1002/ijc.33876. Epub 2021 Dec 2. Int J Cancer. 2022. PMID: 34792199 Free article.
Clinical presentation and outcome of human papillomavirus-positive nasopharyngeal carcinoma in a North American cohort.
Huang SH, Jacinto JCK, O'Sullivan B, Su J, Kim J, Ringash J, Spreafico A, Yu E, Perez-Ordonez B, Weinreb I, Cho J, Hope AJ, Bratman SV, Giuliani ME, Hosni A, Hahn E, Goldstein DP, Tong L, Eng L, Xu W, Waldron JN. Huang SH, et al. Among authors: ringash j. Cancer. 2022 Aug 1;128(15):2908-2921. doi: 10.1002/cncr.34266. Epub 2022 May 19. Cancer. 2022. PMID: 35588085 Free article.
Evaluation of risk-tailored individualized selection of radiation therapy target volume for head and neck carcinoma of unknown primary.
Ghatasheh H, Huang SH, Su J, Xu W, Bratman SV, Cho J, Giuliani M, Hahn E, Hope A, Kim J, O'Sullivan B, Ringash J, Waldron J, Chepeha DB, Irish JC, Goldstein DP, Spreafico A, Tong L, de Almeida JR, Hosni A. Ghatasheh H, et al. Among authors: ringash j. Radiother Oncol. 2022 Oct;175:56-64. doi: 10.1016/j.radonc.2022.07.016. Epub 2022 Jul 26. Radiother Oncol. 2022. PMID: 35905781
Results of radiotherapy for primary subglottic squamous cell carcinoma.
Paisley S, Warde PR, O'Sullivan B, Waldron J, Gullane PJ, Payne D, Liu FF, Bayley A, Ringash J, Cummings BJ. Paisley S, et al. Among authors: ringash j. Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1245-50. doi: 10.1016/s0360-3016(01)02759-6. Int J Radiat Oncol Biol Phys. 2002. PMID: 11955735
A Phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer.
Warde P, O'Sullivan B, Aslanidis J, Kroll B, Lockwood G, Waldron J, Payne D, Bayley A, Ringash J, Kim J, Liu FF, Maxymiw W, Sprague S, Cummings BJ. Warde P, et al. Among authors: ringash j. Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):9-13. doi: 10.1016/s0360-3016(02)02890-0. Int J Radiat Oncol Biol Phys. 2002. PMID: 12182969 Clinical Trial.
Post-operative radiochemotherapy for gastric cancer: adoption and adaptation.
Ringash J, Khaksart SJ, Oza A, Couture J, Japp B, Moore M, Siu LL, Hedley D, Swallow C, Wong S, Cummings B, Kim J, Wong R, Brierley J. Ringash J, et al. Clin Oncol (R Coll Radiol). 2005 Apr;17(2):91-5. doi: 10.1016/j.clon.2004.09.017. Clin Oncol (R Coll Radiol). 2005. PMID: 15830570
Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: effect of dose escalation on pathologic complete response, local recurrence-free survival, disease-free survival, and overall survival.
Wiltshire KL, Ward IG, Swallow C, Oza AM, Cummings B, Pond GR, Catton P, Kim J, Ringash J, Wong CS, Wong R, Siu LL, Moore M, Brierley J. Wiltshire KL, et al. Among authors: ringash j. Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):709-16. doi: 10.1016/j.ijrobp.2005.08.012. Epub 2005 Oct 19. Int J Radiat Oncol Biol Phys. 2006. PMID: 16242252 Clinical Trial.
A dose escalation study of hyperfractionated accelerated radiation delivered with integrated neck surgery (HARDWINS) for the management of advanced head and neck cancer.
Waldron J, Warde P, Irish J, Pintilie M, Sellmann S, Bayley A, Cummings B, Kim J, Liu FF, Payne D, Ringash J, Brown D, Freeman J, Gilbert R, Gullane P, Witterick I, O'Sullivan B. Waldron J, et al. Among authors: ringash j. Radiother Oncol. 2008 May;87(2):173-80. doi: 10.1016/j.radonc.2008.02.014. Epub 2008 Mar 14. Radiother Oncol. 2008. PMID: 18342965 Clinical Trial.
Truths and myths about radiotherapy for verrucous carcinoma of larynx.
Huang SH, Lockwood G, Irish J, Ringash J, Cummings B, Waldron J, Kim J, Dawson LA, Bayley A, Hope A, O'Sullivan B. Huang SH, et al. Among authors: ringash j. Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1110-5. doi: 10.1016/j.ijrobp.2008.05.021. Epub 2008 Aug 15. Int J Radiat Oncol Biol Phys. 2009. PMID: 18707828
Retrospective study of palliative radiotherapy in newly diagnosed head and neck carcinoma.
Stevens CM, Huang SH, Fung S, Bayley AJ, Cho JB, Cummings BJ, Dawson LA, Hope AJ, Kim JJ, O'Sullivan B, Waldron JN, Ringash J. Stevens CM, et al. Among authors: ringash j. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):958-63. doi: 10.1016/j.ijrobp.2010.06.055. Epub 2010 Oct 14. Int J Radiat Oncol Biol Phys. 2011. PMID: 20950952
A randomized controlled trial of lorazepam to reduce liver motion in patients receiving upper abdominal radiation therapy.
Tsang DS, Voncken FE, Tse RV, Sykes J, Wong RK, Dinniwell RE, Kim J, Ringash J, Brierley JD, Cummings BJ, Brade A, Dawson LA. Tsang DS, et al. Among authors: ringash j. Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):881-7. doi: 10.1016/j.ijrobp.2013.08.024. Epub 2013 Oct 9. Int J Radiat Oncol Biol Phys. 2013. PMID: 24119833 Clinical Trial.
Quality of life in patients with K-RAS wild-type colorectal cancer: the CO.20 phase 3 randomized trial.
Ringash J, Au HJ, Siu LL, Shapiro JD, Jonker DJ, Zalcberg JR, Moore MJ, Strickland A, Kotb R, Jeffery M, Alcindor T, Ng S, Salim M, Sabesan S, Easaw JC, Shannon J, El-Tahche F, Walters I, Tu D, O'Callaghan CJ; NCIC Clinical Trials Group; Australasian Gastrointestinal Trials Group. Ringash J, et al. Cancer. 2014 Jan 15;120(2):181-9. doi: 10.1002/cncr.28410. Epub 2013 Oct 11. Cancer. 2014. PMID: 24127364 Free article. Clinical Trial.
Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas.
Huang SH, Xu W, Waldron J, Siu L, Shen X, Tong L, Ringash J, Bayley A, Kim J, Hope A, Cho J, Giuliani M, Hansen A, Irish J, Gilbert R, Gullane P, Perez-Ordonez B, Weinreb I, Liu FF, O'Sullivan B. Huang SH, et al. Among authors: ringash j. J Clin Oncol. 2015 Mar 10;33(8):836-45. doi: 10.1200/JCO.2014.58.6412. Epub 2015 Feb 9. J Clin Oncol. 2015. PMID: 25667292
Clinical outcomes in patients with T4 laryngeal cancer treated with primary radiotherapy versus primary laryngectomy.
Vengalil S, Giuliani ME, Huang SH, McNiven A, Song Y, Xu W, Chan B, Hope A, Cho J, Bayley A, Ringash J, Goldstein D, Razak A, Irish J, Gilbert R, Gullane P, Waldron J, Kim J, O'Sullivan B. Vengalil S, et al. Among authors: ringash j. Head Neck. 2016 Apr;38 Suppl 1:E2035-40. doi: 10.1002/hed.24374. Epub 2016 Feb 1. Head Neck. 2016. PMID: 26828197
Quality of life and swallowing with standard chemoradiotherapy versus accelerated radiotherapy and panitumumab in locoregionally advanced carcinoma of the head and neck: A phase III randomised trial from the Canadian Cancer Trials Group (HN.6).
Ringash J, Waldron JN, Siu LL, Martino R, Winquist E, Wright JR, Nabid A, Hay JH, Hammond A, Sultanem K, Hotte S, Leong C, El-Gayed AA, Naz F, Ramchandar K, Owen TE, Montenegro A, O'Sullivan B, Chen BE, Parulekar WR. Ringash J, et al. Eur J Cancer. 2017 Feb;72:192-199. doi: 10.1016/j.ejca.2016.11.008. Epub 2016 Dec 29. Eur J Cancer. 2017. PMID: 28040660 Clinical Trial.
Phase I trial of radiation therapy and sorafenib in unresectable liver metastases.
Goody RB, Brade AM, Wang L, Craig T, Brierley J, Dinniwell R, Wong RKS, Cho C, Kim J, Kassam Z, Ringash J, Knox JJ, Dawson LA. Goody RB, et al. Among authors: ringash j. Radiother Oncol. 2017 May;123(2):234-239. doi: 10.1016/j.radonc.2017.01.018. Epub 2017 Feb 13. Radiother Oncol. 2017. PMID: 28202227 Clinical Trial.
Lymph node ratio relationship to regional failure and distant metastases in oral cavity cancer.
Hosni A, McMullen C, Huang SH, Xu W, Su J, Bayley A, Bratman SV, Cho J, Giuliani M, Kim J, Ringash J, Waldron J, Spreafico A, Weinreb I, de Almeida JR, Brown DH, Irish JC, O'Sullivan B, Goldstein DP, Hope A. Hosni A, et al. Among authors: ringash j. Radiother Oncol. 2017 Aug;124(2):225-231. doi: 10.1016/j.radonc.2017.06.018. Radiother Oncol. 2017. PMID: 28838425
Long-Term Late Toxicity, Quality of Life, and Emotional Distress in Patients With Nasopharyngeal Carcinoma Treated With Intensity Modulated Radiation Therapy.
McDowell LJ, Rock K, Xu W, Chan B, Waldron J, Lu L, Ezzat S, Pothier D, Bernstein LJ, So N, Huang SH, Giuliani M, Hope A, O'Sullivan B, Bratman SV, Cho J, Kim J, Jang R, Bayley A, Ringash J. McDowell LJ, et al. Among authors: ringash j. Int J Radiat Oncol Biol Phys. 2018 Oct 1;102(2):340-352. doi: 10.1016/j.ijrobp.2018.05.060. Epub 2018 Jun 4. Int J Radiat Oncol Biol Phys. 2018. PMID: 30191868
Predictors of Early Recurrence Prior to Planned Postoperative Radiation Therapy for Oral Cavity Squamous Cell Carcinoma and Outcomes Following Salvage Intensified Radiation Therapy.
Hosni A, Huang SH, Chiu K, Xu W, Su J, Bayley A, Bratman SV, Cho J, Giuliani M, Kim J, O'Sullivan B, Ringash J, Waldron J, Spreafico A, Yu E, de Almeida JR, Monteiro E, Chepeha DB, Irish JC, Goldstein DP, Hope A. Hosni A, et al. Among authors: ringash j. Int J Radiat Oncol Biol Phys. 2019 Feb 1;103(2):363-373. doi: 10.1016/j.ijrobp.2018.09.013. Epub 2018 Sep 21. Int J Radiat Oncol Biol Phys. 2019. PMID: 30244160
A cross sectional study in cognitive and neurobehavioral impairment in long-term nasopharyngeal cancer survivors treated with intensity-modulated radiotherapy.
McDowell LJ, Ringash J, Xu W, Chan B, Lu L, Waldron J, Rock K, So N, Huang SH, Giuliani M, Hope A, O'Sullivan B, Bratman SV, Cho J, Kim J, Jang R, Bayley A, Bernstein LJ. McDowell LJ, et al. Among authors: ringash j. Radiother Oncol. 2019 Feb;131:179-185. doi: 10.1016/j.radonc.2018.09.012. Epub 2018 Sep 29. Radiother Oncol. 2019. PMID: 30279047
Outcomes by treatment modality in elderly patients with localized gastric and esophageal cancer.
Natori A, Chan BA, Sim HW, Ma L, Yokom DW, Chen E, Liu G, Darling G, Swallow C, Brar S, Brierley J, Ringash J, Wong R, Kim J, Rogalla P, Hafezi-Bakhtiari S, Conner J, Knox J, Elimova E, Jang RW. Natori A, et al. Among authors: ringash j. Curr Oncol. 2018 Dec;25(6):366-370. doi: 10.3747/co.25.4208. Epub 2018 Dec 1. Curr Oncol. 2018. PMID: 30607110 Free PMC article.
Prognostic value of clinical and radiologic extranodal extension and their role in the 8th edition TNM cN classification for HPV-negative oropharyngeal carcinoma.
Pilar A, Yu E, Su J, O'Sullivan B, Bartlett E, Waldron JN, Ringash J, Spreafico A, Hansen AR, de Almeida J, Bayley A, Bratman SV, Cho J, Giuliani M, Hope A, Hosni A, Kim J, Tong L, Xu W, Huang SH. Pilar A, et al. Among authors: ringash j. Oral Oncol. 2021 Mar;114:105167. doi: 10.1016/j.oraloncology.2020.105167. Epub 2021 Jan 25. Oral Oncol. 2021. PMID: 33508706
Transitions in oral and gut microbiome of HPV+ oropharyngeal squamous cell carcinoma following definitive chemoradiotherapy (ROMA LA-OPSCC study).
Oliva M, Schneeberger PHH, Rey V, Cho M, Taylor R, Hansen AR, Taylor K, Hosni A, Bayley A, Hope AJ, Bratman SV, Ringash J, Singh S, Weinreb I, Perez-Ordoñez B, Chepeha D, Waldron J, Xu W, Guttman D, Siu LL, Coburn B, Spreafico A. Oliva M, et al. Among authors: ringash j. Br J Cancer. 2021 Apr;124(9):1543-1551. doi: 10.1038/s41416-020-01253-1. Epub 2021 Mar 10. Br J Cancer. 2021. PMID: 33750907 Free PMC article.
The Potential Impact and Usability of the Eighth Edition TNM Staging Classification in Oral Cavity Cancer.
Chiu K, Hosni A, Huang SH, Tong L, Xu W, Lu L, Bayley A, Bratman S, Cho J, Giuliani M, Kim J, Ringash J, Waldron J, Spreafico A, Irish J, Gilbert R, Gullane P, Goldstein D, O'Sullivan B, Hope A. Chiu K, et al. Among authors: ringash j. Clin Oncol (R Coll Radiol). 2021 Oct;33(10):e442-e449. doi: 10.1016/j.clon.2021.05.007. Epub 2021 Jul 11. Clin Oncol (R Coll Radiol). 2021. PMID: 34261594
The PRO-ACTIVE trial protocol: a randomized study comparing the effectiveness of PROphylACTic swallow InterVEntion for patients receiving radiotherapy for head and neck cancer.
Martino R, Fitch MI, Fuller CD, Hope A, Krisciunas G, Langmore SE, Lazarus C, Macdonald CL, McCulloch T, Mills G, Palma DA, Pytynia K, Ringash J, Sultanem K, Theurer J, Thorpe KE, Hutcheson K. Martino R, et al. Among authors: ringash j. BMC Cancer. 2021 Oct 13;21(1):1100. doi: 10.1186/s12885-021-08826-0. BMC Cancer. 2021. PMID: 34645411 Free PMC article.
Development and Validation of an Oral Cavity Cancer Outcomes Prediction Score Incorporating Patient-Derived Xenograft Engraftment.
Id Said B, Ailles L, Karamboulas C, Meens J, Huang SH, Xu W, Keshavarzi S, Bratman SV, Cho BCJ, Giuliani M, Hahn E, Kim J, O'Sullivan B, Ringash J, Waldron J, Spreafico A, de Almeida JR, Chepeha DB, Irish JC, Goldstein DP, Hope A, Hosni A. Id Said B, et al. Among authors: ringash j. JAMA Otolaryngol Head Neck Surg. 2022 Apr 1;148(4):342-349. doi: 10.1001/jamaoto.2022.0003. JAMA Otolaryngol Head Neck Surg. 2022. PMID: 35238880 Free PMC article.
IMRT for adjuvant radiation in gastric cancer: a preferred plan?
Ringash J, Perkins G, Brierley J, Lockwood G, Islam M, Catton P, Cummings B, Kim J, Wong R, Dawson L. Ringash J, et al. Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):732-8. doi: 10.1016/j.ijrobp.2005.03.013. Epub 2005 Jun 22. Int J Radiat Oncol Biol Phys. 2005. PMID: 15978742
A phase I/II study to evaluate the toxicity and efficacy of accelerated fractionation radiotherapy for the palliation of dysphagia from carcinoma of the oesophagus.
Kassam Z, Wong RK, Ringash J, Ung Y, Kamra J, DeBoer G, O'Brien M, Kim J, Loblaw DA, Wong S, Cummings B, Davey P. Kassam Z, et al. Among authors: ringash j. Clin Oncol (R Coll Radiol). 2008 Feb;20(1):53-60. doi: 10.1016/j.clon.2007.10.003. Clin Oncol (R Coll Radiol). 2008. PMID: 18345545 Clinical Trial.
Quality of life in a prospective, multicenter phase 2 trial of neoadjuvant full-dose gemcitabine, oxaliplatin, and radiation in patients with resectable or borderline resectable pancreatic adenocarcinoma.
Serrano PE, Herman JM, Griffith KA, Zalupski MM, Kim EJ, Bekaii-Saab TS, Ben-Josef E, Dawson LA, Ringash J, Wei AC. Serrano PE, et al. Among authors: ringash j. Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):270-7. doi: 10.1016/j.ijrobp.2014.05.053. Epub 2014 Aug 4. Int J Radiat Oncol Biol Phys. 2014. PMID: 25104069 Free PMC article. Clinical Trial.
Salivary duct carcinoma: Treatment, outcomes, and patterns of failure.
Johnston ML, Huang SH, Waldron JN, Atenafu EG, Chan K, Cummings BJ, Gilbert RW, Goldstein D, Gullane PJ, Irish JC, Perez-Ordonez B, Weinreb I, Bayley A, Cho J, Dawson LA, Hope A, Ringash J, Witterick IJ, O'Sullivan B, Kim J. Johnston ML, et al. Among authors: ringash j. Head Neck. 2016 Apr;38 Suppl 1:E820-6. doi: 10.1002/hed.24107. Epub 2015 Jul 15. Head Neck. 2016. PMID: 25916947
Reply to N. Osazuwa-Peters et al.
Ringash J. Ringash J. J Clin Oncol. 2016 Apr 1;34(10):1152. doi: 10.1200/JCO.2015.65.8633. Epub 2016 Jan 19. J Clin Oncol. 2016. PMID: 26786915 No abstract available.
Long-Term Outcomes of Phase 1 and 2 Studies of SBRT for Hepatic Colorectal Metastases.
McPartlin A, Swaminath A, Wang R, Pintilie M, Brierley J, Kim J, Ringash J, Wong R, Dinniwell R, Craig T, Dawson LA. McPartlin A, et al. Among authors: ringash j. Int J Radiat Oncol Biol Phys. 2017 Oct 1;99(2):388-395. doi: 10.1016/j.ijrobp.2017.04.010. Epub 2017 Apr 13. Int J Radiat Oncol Biol Phys. 2017. PMID: 28871989 Clinical Trial.
Radiomic Biomarkers to Refine Risk Models for Distant Metastasis in HPV-related Oropharyngeal Carcinoma.
Kwan JYY, Su J, Huang SH, Ghoraie LS, Xu W, Chan B, Yip KW, Giuliani M, Bayley A, Kim J, Hope AJ, Ringash J, Cho J, McNiven A, Hansen A, Goldstein D, de Almeida JR, Aerts HJ, Waldron JN, Haibe-Kains B, O'Sullivan B, Bratman SV, Liu FF. Kwan JYY, et al. Among authors: ringash j. Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1107-1116. doi: 10.1016/j.ijrobp.2018.01.057. Epub 2018 Feb 1. Int J Radiat Oncol Biol Phys. 2018. PMID: 29506884
The ongoing challenge of large anal cancers: prospective long term outcomes of intensity-modulated radiation therapy with concurrent chemotherapy.
Hosni A, Han K, Le LW, Ringash J, Brierley J, Wong R, Dinniwell R, Brade A, Dawson LA, Cummings BJ, Krzyzanowska MK, Chen EX, Hedley D, Knox J, Easson AM, Lindsay P, Craig T, Kim J. Hosni A, et al. Among authors: ringash j. Oncotarget. 2018 Apr 17;9(29):20439-20450. doi: 10.18632/oncotarget.24926. eCollection 2018 Apr 17. Oncotarget. 2018. PMID: 29755663 Free PMC article.
Prevalence, prognosis, and treatment implications of retropharyngeal nodes in unknown primary head and neck carcinoma.
Horowitz G, Hosni A, Yu E, Xu W, Lu L, Au M, Dixon PR, Brown D, Chepeha DB, Gilbert RW, Goldstein DP, Gullane PJ, Irish JC, Bayley A, Cho J, Giuliani M, Huang SH, Hope A, Kim J, O'Sullivan B, Ringash J, Waldron J, Weinreb I, Perez-Ordonez B, Bratman SV, de Almeida JR. Horowitz G, et al. Among authors: ringash j. Oral Oncol. 2018 Jul;82:162-167. doi: 10.1016/j.oraloncology.2018.05.023. Epub 2018 Jun 1. Oral Oncol. 2018. PMID: 29909891
The Prevalence and Determinants of Return to Work in Nasopharyngeal Carcinoma Survivors.
So N, McDowell LJ, Lu L, Xu W, Rock K, Waldron J, Bernstein LJ, Chan HB, Huang SH, Giuliani M, Hope A, O'Sullivan B, Bratman SV, Cho J, Kim J, Jang R, Bayley A, Ringash J. So N, et al. Among authors: ringash j. Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):134-145. doi: 10.1016/j.ijrobp.2019.09.008. Epub 2019 Sep 27. Int J Radiat Oncol Biol Phys. 2020. PMID: 31568813
Development and validation of a clinical prediction-score model for distant metastases in major salivary gland carcinoma.
Lukovic J, Alfaraj FA, Mierzwa ML, Marta GN, Xu W, Su J, Moraes FY, Huang SH, Bratman SV, O'Sullivan B, Kim JJ, Ringash JG, Waldron J, de Almeida JR, Goldstein DP, Casper KA, Rosko AJ, Spector ME, Kowalski LP, Hope A, Hosni A. Lukovic J, et al. Among authors: ringash jg. Ann Oncol. 2020 Feb;31(2):295-301. doi: 10.1016/j.annonc.2019.10.024. Epub 2019 Dec 16. Ann Oncol. 2020. PMID: 31959347 Free article.
Measuring financial toxicity incurred after treatment of head and neck cancer: Development and validation of the Financial Index of Toxicity questionnaire.
Hueniken K, Douglas CM, Jethwa AR, Mirshams M, Eng L, Hope A, Chepeha DB, Goldstein DP, Ringash J, Hansen A, Martino R, Li M, Liu G, Xu W, de Almeida JR. Hueniken K, et al. Among authors: ringash j. Cancer. 2020 Sep 1;126(17):4042-4050. doi: 10.1002/cncr.33032. Epub 2020 Jun 30. Cancer. 2020. PMID: 32603521 Free article.
A Risk Score Model for Locoregional Recurrence Following Upfront Surgery for Pancreatic Adenocarcinoma: Implications for Adjuvant Therapy.
Elamir AM, Hutchinson S, Albaba H, Keshavarzi S, Xu W, Moulton CA, McGilvary I, Cleary S, Wei A, Dodd A, Knox J, O'Kane G, Prince RM, Kalimuthu S, Kim J, Ringash J, Dawson LA, Wong R, Barry A, Brierley J, Gallinger S, Hosni A. Elamir AM, et al. Among authors: ringash j. Clin Oncol (R Coll Radiol). 2021 Aug;33(8):527-535. doi: 10.1016/j.clon.2021.03.007. Epub 2021 Apr 17. Clin Oncol (R Coll Radiol). 2021. PMID: 33875360
Anal Adenocarcinoma: A Rare Entity in Need of Multidisciplinary Management.
Lukovic J, Kim JJ, Liu ZA, Cummings BJ, Brierley JD, Wong RKS, Ringash JG, Dawson LA, Barry A, Krzyzanowska MK, Chen EX, Hedley DW, Quereshy FA, Swallow CJ, Gryfe RN, Kennedy ED, Easson AM, Hosni A. Lukovic J, et al. Among authors: ringash jg. Dis Colon Rectum. 2022 Feb 1;65(2):189-197. doi: 10.1097/DCR.0000000000002281. Dis Colon Rectum. 2022. PMID: 34990422
The collateral impact of the COVID-19 pandemic on HPV-positive oropharyngeal cancer diagnosis.
Ballal Y, Gete M, Su J, O'Sullivan B, Waldron JN, Irish J, Ringash J, Kim J, Bratman S, Cho J, Hope AJ, Hosni A, de Almeida J, Goldstein DP, Witterick I, Monteiro E, Tong L, Xu W, Hui Huang S, Hahn E. Ballal Y, et al. Among authors: ringash j. Oral Oncol. 2023 Mar;138:106332. doi: 10.1016/j.oraloncology.2023.106332. Epub 2023 Feb 3. Oral Oncol. 2023. PMID: 36780824 Free PMC article.
Tolerability of the Intergroup 0099 (INT 0099) regimen in locally advanced nasopharyngeal cancer with a focus on patients' nutritional status.
Bahl M, Siu LL, Pond GR, Kim J, Tannock IF, Bayley A, Cummings BJ, Waldron J, Ringash J, Chen EX, Gitterman L, Lemon B, O'Sullivan B. Bahl M, et al. Among authors: ringash j. Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1127-36. doi: 10.1016/j.ijrobp.2004.05.011. Int J Radiat Oncol Biol Phys. 2004. PMID: 15519784
Esthesioneuroblastoma: The Princess Margaret Hospital experience.
Bachar G, Goldstein DP, Shah M, Tandon A, Ringash J, Pond G, Gullane PJ, Perez-Ordonez B, Gilbert RW, Brown DH, Gentili F, O'Sullivan B, Irish JC. Bachar G, et al. Among authors: ringash j. Head Neck. 2008 Dec;30(12):1607-14. doi: 10.1002/hed.20920. Head Neck. 2008. PMID: 18798301
Point-of-care outcome assessment in the cancer clinic: audit of data quality.
Wong K, Huang SH, O'Sullivan B, Lockwood G, Dale D, Michaelson T, Waldron J, Bayley A, Cummings B, Dawson LA, Kim J, Liu G, Ringash J. Wong K, et al. Among authors: ringash j. Radiother Oncol. 2010 Jun;95(3):339-43. doi: 10.1016/j.radonc.2010.03.015. Epub 2010 Mar 31. Radiother Oncol. 2010. PMID: 20362349
Baseline Albumin-Bilirubin (ALBI) Score in Western Patients With Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy (SBRT).
Murray LJ, Sykes J, Brierley J, Kim JJ, Wong RKS, Ringash J, Craig T, Velec M, Lindsay P, Knox JJ, Dawson LA. Murray LJ, et al. Among authors: ringash j. Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):900-909. doi: 10.1016/j.ijrobp.2018.04.011. Epub 2018 Apr 12. Int J Radiat Oncol Biol Phys. 2018. PMID: 29976502 Clinical Trial.
Prognostic importance of radiologic extranodal extension in nasopharyngeal carcinoma treated in a Canadian cohort.
Chin O, Yu E, O'Sullivan B, Su J, Tellier A, Siu L, Waldron J, Kim J, Hansen A, Hope A, Cho J, Giuliani M, Ringash J, Spreafico A, Bratman S, Hosni A, Hahn E, Tong L, Xu W, Huang SH. Chin O, et al. Among authors: ringash j. Radiother Oncol. 2021 Dec;165:94-102. doi: 10.1016/j.radonc.2021.10.018. Epub 2021 Oct 27. Radiother Oncol. 2021. PMID: 34718052
Health related quality of life outcomes following stereotactic body radiotherapy in patients with oligo-metastatic disease: A systematic review and individual patient data meta-analysis.
Barry AS, Helou J, Bezjak A, Wong R, Dawson LA, Ringash J, Fazelzad R, Liu Z, Olson R, Palma D, Ost P, Siva S, Phillips R, Adhikari NKJ. Barry AS, et al. Among authors: ringash j. Radiother Oncol. 2022 Aug;173:163-169. doi: 10.1016/j.radonc.2022.05.033. Epub 2022 Jun 6. Radiother Oncol. 2022. PMID: 35680076
Patient-Reported and Clinical Outcomes From 5-Fraction SBRT for Oligometastases: A Prospective Single-Institution Study.
Wong RKS, Liu ZA, Barry A, Rogalla P, Bezjak A, Brierley JD, Dawson LA, Giuliani M, Kim J, Ringash J, Sun A, Chung P, Hope A, Shessel A, Lindsay P. Wong RKS, et al. Among authors: ringash j. Int J Radiat Oncol Biol Phys. 2022 Dec 1;114(5):1000-1010. doi: 10.1016/j.ijrobp.2022.07.025. Epub 2022 Jul 25. Int J Radiat Oncol Biol Phys. 2022. PMID: 35901981 Free article.
Local excision and postoperative radiotherapy for distal rectal cancer.
Benson R, Wong CS, Cummings BJ, Brierley J, Catton P, Ringash J, Abdolell M. Benson R, et al. Among authors: ringash j. Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1309-16. doi: 10.1016/s0360-3016(01)01545-0. Int J Radiat Oncol Biol Phys. 2001. PMID: 11483343
Rectal motion in patients receiving preoperative radiotherapy for carcinoma of the rectum.
Brierley JD, Dawson LA, Sampson E, Bayley A, Scott S, Moseley JL, Craig T, Cummings B, Dinniwell R, Kim JJ, Ringash J, Wong R, Brock KK. Brierley JD, et al. Among authors: ringash j. Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):97-102. doi: 10.1016/j.ijrobp.2010.01.042. Int J Radiat Oncol Biol Phys. 2011. PMID: 21481722
Randomized Trial Comparing Radiologic Pigtail Gastrostomy and Peroral Image-Guided Gastrostomy: Intra- and Postprocedural Pain, Radiation Exposure, Complications, and Quality of Life.
Bernstein OA, Campbell J, Rajan DK, Kachura JR, Simons ME, Beecroft JR, Jaskolka JD, Ringash J, Ho CS, Tan KT. Bernstein OA, et al. Among authors: ringash j. J Vasc Interv Radiol. 2015 Nov;26(11):1680-6; quiz 1686. doi: 10.1016/j.jvir.2015.07.012. Epub 2015 Aug 24. J Vasc Interv Radiol. 2015. PMID: 26316137 Clinical Trial.
Effect of Standard Radiotherapy With Cisplatin vs Accelerated Radiotherapy With Panitumumab in Locoregionally Advanced Squamous Cell Head and Neck Carcinoma: A Randomized Clinical Trial.
Siu LL, Waldron JN, Chen BE, Winquist E, Wright JR, Nabid A, Hay JH, Ringash J, Liu G, Johnson A, Shenouda G, Chasen M, Pearce A, Butler JB, Breen S, Chen EX, FitzGerald TJ, Childs TJ, Montenegro A, O'Sullivan B, Parulekar WR. Siu LL, et al. Among authors: ringash j. JAMA Oncol. 2017 Feb 1;3(2):220-226. doi: 10.1001/jamaoncol.2016.4510. JAMA Oncol. 2017. PMID: 27930762
Regional Recurrences and Hyams Grade in Esthesioneuroblastoma.
Ziai H, Yu E, Weinreb I, Perez-Ordonez B, Yao CMKL, Xu W, Yang D, Witterick IJ, Monteiro E, Gilbert RW, Irish JC, Gullane PJ, Goldstein DP, Ringash J, Bayley A, de Almeida JR. Ziai H, et al. Among authors: ringash j. J Neurol Surg B Skull Base. 2020 Oct 5;82(6):608-614. doi: 10.1055/s-0040-1715809. eCollection 2021 Dec. J Neurol Surg B Skull Base. 2020. PMID: 34745827 Free PMC article.
Impact of Definitive Chemoradiation on Quality-of-Life Changes for Patients With Anal Cancer: Long-term Results of a Prospective Study.
Hosni A, Ringash J, Han K, Liu ZA, Brierley JD, Wong RKS, Dawson LA, Cummings BJ, Krzyzanowska MK, Chen EX, Hedley D, Knox JJ, Easson AM, Lindsay P, Craig T, Kim J. Hosni A, et al. Among authors: ringash j. Dis Colon Rectum. 2022 May 1;65(5):642-653. doi: 10.1097/DCR.0000000000002385. Dis Colon Rectum. 2022. PMID: 35067501
Outcome and treatment toxicity in east-indian versus white-canadian patients with oral cavity cancer following postoperative (chemo-)radiotherapy delivered under similar multidisciplinary care: A propensity-matched cohort study.
Gudi S, O'Sullivan B, Hosni A, Su J, Hope A, Ringash J, Hueniken K, Liu G, Tong L, Goldstein D, de Almeida J, Hansen AR, Bratman SV, Cho J, Giuliani M, Hahn E, Kim J, Xu W, Waldron J, Huang SH. Gudi S, et al. Among authors: ringash j. Oral Oncol. 2021 Sep;120:105419. doi: 10.1016/j.oraloncology.2021.105419. Epub 2021 Jun 25. Oral Oncol. 2021. PMID: 34175612
Intraobserver and interobserver variability in GTV delineation on FDG-PET-CT images of head and neck cancers.
Breen SL, Publicover J, De Silva S, Pond G, Brock K, O'Sullivan B, Cummings B, Dawson L, Keller A, Kim J, Ringash J, Yu E, Hendler A, Waldron J. Breen SL, et al. Among authors: ringash j. Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):763-70. doi: 10.1016/j.ijrobp.2006.12.039. Epub 2007 Mar 26. Int J Radiat Oncol Biol Phys. 2007. PMID: 17379435
Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial.
Ediebah DE, Coens C, Zikos E, Quinten C, Ringash J, King MT, Schmucker von Koch J, Gotay C, Greimel E, Flechtner H, Weis J, Reeve BB, Smit EF, Taphoorn MJ, Bottomley A. Ediebah DE, et al. Among authors: ringash j. Br J Cancer. 2014 May 13;110(10):2427-33. doi: 10.1038/bjc.2014.208. Epub 2014 Apr 17. Br J Cancer. 2014. PMID: 24743709 Free PMC article.
In Regard to Yerramilli et al's "Palliative Radiotherapy for Oncologic Emergencies in the Setting of COVID-19: Approaches to Balancing Risks and Benefits".
Hahn E, Livergant J, Millar BA, Ringash J, Wong R, Dawson LA, Warde P, Cummings B, Barry A. Hahn E, et al. Among authors: ringash j. Adv Radiat Oncol. 2020 May 11;5(4):595-596. doi: 10.1016/j.adro.2020.04.017. eCollection 2020 Jul-Aug. Adv Radiat Oncol. 2020. PMID: 32395670 Free PMC article. No abstract available.
Sexual satisfaction in nasopharyngeal carcinoma survivors: Rates and determinants.
McDowell L, So N, Keshavarzi S, Xu W, Rock K, Chan B, Waldron J, Bernstein LJ, Hui Huang S, Giuliani M, Hope A, O'Sullivan B, Bratman SV, Cho J, Kim J, Jang R, Bayley A, Ringash J. McDowell L, et al. Among authors: ringash j. Oral Oncol. 2020 Jul 14;109:104865. doi: 10.1016/j.oraloncology.2020.104865. Online ahead of print. Oral Oncol. 2020. PMID: 32679542
Short and Simple Palliative Radiation Therapy.
Hosni A, Kim J, Dawson L, Ringash J. Hosni A, et al. Among authors: ringash j. Int J Radiat Oncol Biol Phys. 2022 Mar 1;112(3):583-584. doi: 10.1016/j.ijrobp.2019.07.024. Int J Radiat Oncol Biol Phys. 2022. PMID: 35101190 No abstract available.
Impact of the COVID-19 Pandemic on Canadian Radiation Oncology Practices.
Doll CM, Wakefield DV, Ringash J, Ingledew PA, Dawson LA, Eichler T, Schwartz DL. Doll CM, et al. Among authors: ringash j. Int J Radiat Oncol Biol Phys. 2022 Jul 1;113(3):513-517. doi: 10.1016/j.ijrobp.2022.03.017. Epub 2022 Mar 19. Int J Radiat Oncol Biol Phys. 2022. PMID: 35318953 Free PMC article.
The Impact of Disease Progression on Health-Related Quality of Life Outcomes in Patients With Oligometastatic Disease at 12 Months Post Stereotactic Body Radiation Therapy.
Barry AS, Bezjak A, Helou J, Goodwin P, Kiss A, Ringash J, Goody R, Munoz-Schuffenegger P, Lindsay PE, Pellizzari A, Ponichtera J, Liu ZH, Wong R. Barry AS, et al. Among authors: ringash j. Int J Radiat Oncol Biol Phys. 2022 Dec 1;114(5):989-999. doi: 10.1016/j.ijrobp.2022.07.012. Epub 2022 Jul 28. Int J Radiat Oncol Biol Phys. 2022. PMID: 35907512
Individualized risk assessment of distant metastases in oral cavity carcinoma: a validated predictive-score model.
Id Said B, Alfaraj FA, Marta GN, Kowalski LP, Kohler HF, Huang SH, Su J, Xu W, Eng L, de Moraes FY, Hahn E, Kim JJ, O'Sullivan B, Ringash J, Waldron J, Matos LL, Prisman E, Irish JC, Yao CMKL, de Almeida JR, Goldstein DP, Hope A, Hosni A. Id Said B, et al. Among authors: ringash j. J Natl Cancer Inst. 2023 Dec 6;115(12):1555-1562. doi: 10.1093/jnci/djad144. J Natl Cancer Inst. 2023. PMID: 37498564 Clinical Trial.
Accuracy of ultrasound in localization of breast boost field.
Ringash J, Whelan T, Elliott E, Minuk T, Sanders K, Lukka H, Reiter H. Ringash J, et al. Radiother Oncol. 2004 Jul;72(1):61-6. doi: 10.1016/j.radonc.2004.03.013. Radiother Oncol. 2004. PMID: 15236875 Clinical Trial.
Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials.
Maringwa JT, Quinten C, King M, Ringash J, Osoba D, Coens C, Martinelli F, Vercauteren J, Cleeland CS, Flechtner H, Gotay C, Greimel E, Taphoorn MJ, Reeve BB, Koch JS, Weis J, Smit EF, van Meerbeeck JP, Bottomley A; EORTC PROBE project and the Lung Cancer Group. Maringwa JT, et al. Among authors: ringash j. Support Care Cancer. 2011 Nov;19(11):1753-60. doi: 10.1007/s00520-010-1016-5. Epub 2010 Oct 1. Support Care Cancer. 2011. PMID: 20886240
Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients.
Maringwa J, Quinten C, King M, Ringash J, Osoba D, Coens C, Martinelli F, Reeve BB, Gotay C, Greimel E, Flechtner H, Cleeland CS, Schmucker-Von Koch J, Weis J, Van Den Bent MJ, Stupp R, Taphoorn MJ, Bottomley A; EORTC PROBE Project and Brain Cancer Group. Maringwa J, et al. Among authors: ringash j. Ann Oncol. 2011 Sep;22(9):2107-2112. doi: 10.1093/annonc/mdq726. Epub 2011 Feb 15. Ann Oncol. 2011. PMID: 21324954 Free article. Clinical Trial.
Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data.
Martinelli F, Quinten C, Maringwa JT, Coens C, Vercauteren J, Cleeland CS, Flechtner H, Gotay C, Greimel E, King M, Mendoza T, Osoba D, Reeve BB, Ringash J, Koch JS, Shi Q, Taphoorn MJ, Weis J, Bottomley A; European Organisation for Research and Treatment of Cancer Clinical Groups. Martinelli F, et al. Among authors: ringash j. Expert Rev Pharmacoecon Outcomes Res. 2011 Oct;11(5):587-99. doi: 10.1586/erp.11.51. Expert Rev Pharmacoecon Outcomes Res. 2011. PMID: 21958103
257 results